Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Our adviser: Drugs Infromation online


             
 

Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.

Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.

Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.

Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.

Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.



NAVIGATION


         

 

How we move is an excellent indicator of overall health. When we feel good, we move around continually. When we’re in pain, we reduce our physical activity. This observation might seem trivial, but it has led to an original approach for evaluating chronic pain…

 

Long duration, controllable drug delivery is of wide interest to medical researchers and clinicians, particularly those seeking to improve treatment for patients with chronic pain or to prevent cancer recurrence after surgery…

 

A small study published online in the Journal of NeuroInterventional Surgery shows that a technique in which highly concentrated beams of radiation are used, known as Cyberknife, can relieve the stabbing pain of the facial nerve condition trigeminal neuralgia…

 

A 76-year-old man suffering from agonizing post-stroke shoulder pain for more than ten years is now pain-free, thanks to the world’s first implantation of an investigational pain therapy device from SPR™ Therapeutics…

 

A diagnostic tool that yields an objective physiological assessment of whether someone is in pain, as opposed to relying on self-reported measures, is being developed by researchers at the Stanford University School of Medicine in Palo Alto, California…

 

Researchers from the Stanford University School of Medicine have taken a first step toward developing a diagnostic tool that could eliminate a major hurdle in pain medicine - the dependency on self-reporting to measure the presence or absence of pain. The new tool would use patterns of brain activity to give an objective physiologic assessment of whether someone is in pain…

 

Zyga Technology, Inc. announced that the first European patients were enrolled and treated in its GLYDER Facet Resurfacing System Clinical Study. The purpose of the GLYDER clinical study is to evaluate the safety and effectiveness of the GLYDER device in patients with a history of facet pain demonstrated by treatment history and diagnosis as a baseline…

 

Anesthesiology researchers have shown that a device approved by the Food and Drug Administration to reduce the risk that patients will recall their surgery does not lower the risk of the problem, known as intraoperative awareness, any more than a less expensive method. The new study, published Aug…

 

BellaNovus Development Company LLC, a medical design and manufacturing company, today announced its launch of the Ouchless™ Needle Collection. The devices provide doctors and other clinicians an innovative alternative to numbing creams and ice currently used to minimize localized pain resulting from cosmetic injectables, such as Botox® and dermal fillers…

 

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the Australian market launch of the Epiducer(TM) lead delivery system for neurostimulation therapy for the management of chronic pain…




May 2012
Mon Tue Wed Thu Fri Sat Sun
« Apr    
 123456
78910111213
14151617181920
21222324252627
28293031